Clinical Trial Update: A Phase II Study for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase II trial for indolent non-follicular non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Indolent Non-follicular, Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED